Literature DB >> 27193753

The effectiveness and safety of two prophylactic antibiotic regimes in hip-fracture surgery.

Iftikhar Ahmed1, M A Khan2, V Allgar3, A Mohsen2.   

Abstract

Antibiotic prophylaxis with cefuroxime can reduce the incidence of deep wound infection (DWI) in hip-fracture surgery, but may increase the risk of C. difficile infection (CDI). An alternative is gentamicin with beta-lactam for which a question exists around clinical effectiveness and safety, given the gentamicin-associated nephrotoxicity particularly in the elderly and narrower sensitivity spectrum. We compared 744 consecutive patients (group I-cefuroxime) with 756 in group II (gentamicin + flucloxacillin) who were well matched. There were 4 cases of CDI in the cefuroxime prophylaxis, whereas none in flucloxacillin plus gentamicin (group II). There was a statistically significant (p = 0.036) increased DWI rate in group II (2.5 %) as compared to group I (1.1 %). However, after controlling for age, gender, ASA grade, surgeon grade, implant type and type of anaesthesia, there was no statistically significant difference between the two groups (p = 0.146). 8.5 % of group I and 16.5 % of group II developed AKI post-operatively (p = 0.023); however, 79 % of group I and 80 % of in group II had complete resolution of AKI prior to their discharge. Further, a significant increase in inpatient deaths (p = 0.057) in group II was observed, but not at 30 days (p = 0.378).

Entities:  

Keywords:  Antibiotic prophylaxis; Deep wound infection; Hip fracture; Surgery

Mesh:

Substances:

Year:  2016        PMID: 27193753     DOI: 10.1007/s00590-016-1794-7

Source DB:  PubMed          Journal:  Eur J Orthop Surg Traumatol        ISSN: 1633-8065


  32 in total

1.  A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses.

Authors:  W J Munckhof; M L Grayson; J D Turnidge
Journal:  J Antimicrob Chemother       Date:  1996-04       Impact factor: 5.790

2.  Clostridium difficile in patients undergoing primary hip and knee replacement.

Authors:  P J Jenkins; K Teoh; P M Simpson; J Dave; A H W R Simpson; S Breusch
Journal:  J Bone Joint Surg Br       Date:  2010-07

3.  Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity.

Authors:  M J Rybak; B J Abate; S L Kang; M J Ruffing; S A Lerner; G L Drusano
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

4.  Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy.

Authors:  J M Prins; G J Weverling; K de Blok; R J van Ketel; P Speelman
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

5.  Single-dose cefuroxime with gentamicin reduces Clostridium difficile-associated disease in hip-fracture patients.

Authors:  I Starks; G Ayub; G Walley; J Orendi; P Roberts; N Maffulli
Journal:  J Hosp Infect       Date:  2008-07-14       Impact factor: 3.926

6.  An analysis of renal dysfunction in 1511 patients with fractured neck of femur: the implications for peri-operative analgesia.

Authors:  S M White; N Rashid; A Chakladar
Journal:  Anaesthesia       Date:  2009-10       Impact factor: 6.955

7.  Clostridium difficile--associated disease in a setting of endemicity: identification of novel risk factors.

Authors:  Erik R Dubberke; Kimberly A Reske; Yan Yan; Margaret A Olsen; L Clifford McDonald; Victoria J Fraser
Journal:  Clin Infect Dis       Date:  2007-12-15       Impact factor: 9.079

8.  Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea.

Authors:  Mark H Wilcox; Jane Freeman; Warren Fawley; Sarah MacKinlay; Alex Brown; Katrina Donaldson; Oliver Corrado
Journal:  J Antimicrob Chemother       Date:  2004-05-26       Impact factor: 5.790

Review 9.  Aminoglycosides: nephrotoxicity.

Authors:  M P Mingeot-Leclercq; P M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

10.  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.

Authors:  Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more
  4 in total

Review 1.  Adverse effects of a single dose of gentamicin in adults: a systematic review.

Authors:  Rachel S Hayward; Jan Harding; Rob Molloy; Lucy Land; Kate Longcroft-Neal; David Moore; Jonathan D C Ross
Journal:  Br J Clin Pharmacol       Date:  2017-11-03       Impact factor: 4.335

2.  Antibiotic prophylaxis as a quality of care indicator: does it help in the fight against surgical site infections following fragility hip fractures?

Authors:  Tal Frenkel Rutenberg; Anat Aizer; Avraham Levi; Noa Naftali; Shelly Zeituni; Steven Velkes; Anat Aka Zohar
Journal:  Arch Orthop Trauma Surg       Date:  2020-11-20       Impact factor: 3.067

3.  Combination probiotics may prevent Clostridium difficile infection among elderly patients undergoing an orthopedic surgery.

Authors:  Takahiko Nagamine; Yoshinobu Matsumoto; Masaru Nakamura
Journal:  Biosci Microbiota Food Health       Date:  2018-08-30

4.  Surgical site infection after hip fracture surgery: a systematic review and meta-analysis of studies published in the UK.

Authors:  James Masters; David Metcalfe; Joon Soo Ha; Andrew Judge; Matthew L Costa
Journal:  Bone Joint Res       Date:  2020-09-03       Impact factor: 5.853

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.